Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical evaluation of the synbiotic Prodefen Plus® in the prevention of the antibiotic-associated diarrhoea in subjects requiring antibiotic treatment.
Guridi CB, Serena AR, Cabrera SG, Fernández IA, Hernández CR, Vivanco BM, Melguizo MC, Suárez-Almarza J, Nieto-Magro C. Guridi CB, et al. Among authors: nieto magro c. Benef Microbes. 2020 Oct 12;11(6):535-545. doi: 10.3920/BM2020.0062. Epub 2020 Oct 9. Benef Microbes. 2020. PMID: 33032474 Clinical Trial.
A Multicenter, Prospective, Randomized Controlled Trial to Evaluate the Additional Benefit of a Multistrain Synbiotic (Prodefen®) in the Clinical Management of Acute Viral Diarrhea in Children.
García-Menor E, García-Marín F, Vecino-López R, Horcajo-Martínez G, de Ibarrondo Guerrica-Echevarría MJ, Gómez-González P, Velasco-Ortega S, Suárez-Almarza J, Nieto-Magro C. García-Menor E, et al. Among authors: nieto magro c. Glob Pediatr Health. 2016 Nov 18;3:2333794X16679587. doi: 10.1177/2333794X16679587. eCollection 2016. Glob Pediatr Health. 2016. PMID: 28229091 Free PMC article.
Efficacy and safety of ultra-low dose 0.005% estriol vaginal gel for the treatment of vulvovaginal atrophy in postmenopausal women with early breast cancer treated with nonsteroidal aromatase inhibitors: a phase II, randomized, double-blind, placebo-controlled trial.
Hirschberg AL, Sánchez-Rovira P, Presa-Lorite J, Campos-Delgado M, Gil-Gil M, Lidbrink E, Suárez-Almarza J, Nieto-Magro C. Hirschberg AL, et al. Among authors: nieto magro c. Menopause. 2020 May;27(5):526-534. doi: 10.1097/GME.0000000000001497. Menopause. 2020. PMID: 32049923 Free PMC article. Clinical Trial.
A Phase II Prospective, Randomized, Double-Blind, Placebo-Controlled and Multicenter Clinical Trial to Assess the Safety of 0.005% Estriol Vaginal Gel in Hormone Receptor-Positive Postmenopausal Women with Early Stage Breast Cancer in Treatment with Aromatase Inhibitor in the Adjuvant Setting.
Sánchez-Rovira P, Hirschberg AL, Gil-Gil M, Bermejo-De Las Heras B, Nieto-Magro C. Sánchez-Rovira P, et al. Among authors: nieto magro c. Oncologist. 2020 Dec;25(12):e1846-1854. doi: 10.1634/theoncologist.2020-0417. Epub 2020 Jun 9. Oncologist. 2020. PMID: 32459035 Free PMC article. Clinical Trial.
Bioavailability of Oniria®, a Melatonin Prolonged-Release Formulation, Versus Immediate-Release Melatonin in Healthy Volunteers.
Román Martinez M, García Aguilar E, Martin Vílchez S, González García J, Luquero-Bueno S, Camargo-Mamani P, Mejia-Abril G, García-Castro L, de Miguel-Cáceres A, Saz-Leal P, Abad-Santos F, Nieto Magro C, Ochoa Mazarro D. Román Martinez M, et al. Among authors: nieto magro c. Drugs R D. 2022 Sep;22(3):235-243. doi: 10.1007/s40268-022-00394-3. Epub 2022 Aug 2. Drugs R D. 2022. PMID: 35918587 Free PMC article. Clinical Trial.
11 results